Unlocking Success: Lindus Health Enhances All-in-One CRO Services with Powerful In-House Patient Recruitment

BOSTON, Oct. 9, 2025 — Lindus Health, known for its fast and dependable clinical trials, is enhancing its recruitment strategies. These improvements are essential to its complete trial solution. The company takes a modern, tech-focused approach to recruiting patients, making it a standout player in the clinical trial landscape.

Recruiting and retaining patients is a major hurdle in clinical trials, often leading to delays and increased costs. Research shows that about 82% of clinical trials experience sluggish enrollment. Lindus Health has managed to break this trend, achieving enrollment rates that are, on average, 72.9% faster than traditional methods. Their success earned them the CRO Award for Outstanding Patient Recruitment and Retention, highlighting their effectiveness in this challenging area.

Lindus Health’s integrated approach combines various strategies to streamline the recruitment process. They utilize a comprehensive system that focuses on real-time management and coordination. According to Meri Beckwith, Co-CEO of Lindus Health, their model builds trust and interest among potential participants, leading to higher enrollment rates.

The recruitment process follows three main steps:

1. Tailored Recruitment: Using over 40 million electronic medical records (EMRs), Lindus employs AI to identify potential trial candidates based on specific criteria. This includes everything from digital advertising to collaborations with healthcare networks.
2. Centralized Screening: An in-house Patient Recruitment Coordinator (PRC) team manages relationships with patients. They ensure a smooth experience through virtual screenings and direct support, assisted by AI when necessary.
3. Flexible Enrollment Options: Lindus provides various enrollment pathways, allowing participants to choose between virtual sites or local clinics, depending on their preferences.

Combining data, technology, and a patient-focused approach, Lindus Health aims to resolve the inefficiencies in clinical trials. Michael Young, Co-CEO, states, “Faster, more inclusive recruitment is central to our vision.”

Lindus Health is reshaping clinical trials for biotech and medical device companies, focusing on speed and reliability. With over $80 million in funding from notable investors, they are positioned to transform how clinical trials are conducted worldwide, from diabetes to mental health research.

By aligning performance-based pricing with innovative methods, Lindus Health is not just another clinical research organization—it’s a game changer in the industry.

Source link

Lindus Health